APOL1 and lupus nephritis: The role of immune activation in AMKD has been seen in HIV-associated nephropathy, lupus nephritis, and COVID-19-associated nephropathy (14, 72–75), highlighting the potential impact of immune cell function dysregulated by risk-variant forms of APOL1.